These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38641602)

  • 21. The Effect of Peer-Led Navigation Approach as a Form of Task Shifting in Promoting Cervical Cancer Screening Knowledge, Intention, and Practices Among Urban Women in Tanzania: A Randomized Controlled Trial.
    Mboineki JF; Wang P; Dhakal K; Getu MA; Chen C
    Cancer Control; 2022; 29():10732748221089480. PubMed ID: 35666651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.
    Tron L; Lert F; Spire B; Dray-Spira R;
    HIV Med; 2017 Mar; 18(3):181-195. PubMed ID: 28967199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical cancer screening and its associated factors among women of reproductive age in Kenya: further analysis of Kenyan demographic and health survey 2022.
    Gebreegziabher ZA; Semagn BE; Kifelew Y; Abebaw WA; Tilahun WM
    BMC Public Health; 2024 Mar; 24(1):741. PubMed ID: 38459446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic comorbidities and cervical cancer screening and adherence among US-born and foreign-born women.
    Cofie LE; Hirth JM; Wong R
    Cancer Causes Control; 2018 Nov; 29(11):1105-1113. PubMed ID: 30353481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low uptake of cervical cancer screening among HIV positive women in Gondar University referral hospital, Northwest Ethiopia: cross-sectional study design.
    Nega AD; Woldetsadik MA; Gelagay AA
    BMC Womens Health; 2018 Jun; 18(1):87. PubMed ID: 29879969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with utilization of cervical cancer screening services among HIV-positive women aged 18 to 49 years at Lira regional referral hospital, Northern Uganda.
    Layet F; Murungi T; Ashaba N; Kigongo E; Opollo MS
    BMC Womens Health; 2024 Feb; 24(1):114. PubMed ID: 38347497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-World Cervical Cancer Screening Uptake and Predictors of Visual Inspection With Acetic Acid Positivity Among Women Living With HIV in Care Programs in Western Kenya.
    Mungo C; Orang'o O; Ofner S; Musick B; Yiannoutsos C; Cohen CR; Brown D; Wools-Kaloustian K; Semeere A
    JCO Glob Oncol; 2024 Feb; 10():e2300311. PubMed ID: 38359369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya.
    Choi Y; Ibrahim S; Park LP; Cohen CR; Bukusi EA; Huchko MJ
    BMC Womens Health; 2022 Apr; 22(1):122. PubMed ID: 35436908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of an Intervention in General Practice to Increase the Participation of Immigrants in Cervical Cancer Screening: A Cluster Randomized Clinical Trial.
    Møen KA; Kumar B; Igland J; Diaz E
    JAMA Netw Open; 2020 Apr; 3(4):e201903. PubMed ID: 32236530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demographic, knowledge, attitudinal, and accessibility factors associated with uptake of cervical cancer screening among women in a rural district of Tanzania: three public policy implications.
    Lyimo FS; Beran TN
    BMC Public Health; 2012 Jan; 12():22. PubMed ID: 22233530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia.
    Mwanahamuntu MH; Sahasrabuddhe VV; Blevins M; Kapambwe S; Shepherd BE; Chibwesha C; Pfaendler KS; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Stringer JS; Parham GP
    PLoS One; 2013; 8(9):e74607. PubMed ID: 24058599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, Tanzania.
    Cunningham MS; Skrastins E; Fitzpatrick R; Jindal P; Oneko O; Yeates K; Booth CM; Carpenter J; Aronson KJ
    BMJ Open; 2015 Mar; 5(3):e005828. PubMed ID: 25757944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The determinants of cervical cancer screening uptake in women with obesity: application of the Andersen's behavioral model to the CONSTANCES survey.
    Franck JE; Ringa V; Cœuret-Pellicer M; Chauvin P; Menvielle G
    Cancer Causes Control; 2020 Jan; 31(1):51-62. PubMed ID: 31797124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between human papillomavirus and cervical high-grade cytology among HIV-positive and HIV-negative Tanzanian women: A cross-sectional study.
    Swai P; Kjaer SK; Mchome B; Manongi R; Msuya SE; Wu CS; Waldstrom M; Iftner T; Mwaiselage J; Rasch V
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):775-785. PubMed ID: 33512002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing the prevalence of cervical cancer screening in Malaysia: a nationwide survey.
    Chan YM; Ismail MZH; Khaw WF
    BMC Womens Health; 2023 Jul; 23(1):389. PubMed ID: 37491253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving uptake of cervical cancer screening services for women living with HIV and attending chronic care services in rural Malawi.
    Talama GC; Shaw M; Maloya J; Chihana T; Nazimera L; Wroe EB; Kachimanga C
    BMJ Open Qual; 2020 Sep; 9(3):. PubMed ID: 32928783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV status, age at cervical Cancer screening and cervical cytology outcomes in an opportunistic screening setting in Nigeria: a 10-year Cross sectional data analysis.
    Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Silas O; Sagay AS; Anorlu R; Mehta SD; Wehbe F; Simon MA; Adewole IF; Hou L; Murphy RL
    Infect Agent Cancer; 2019; 14():43. PubMed ID: 31798680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Social disparities in access to breast and cervical cancer screening by women living in Spain.
    Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
    Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regularity of cervical cancer screening in Korea: analysis using national public data for 12 years.
    Kim JY; Hong J; Yoon J; Park J; Kim TH
    J Gynecol Oncol; 2024 Mar; 35(2):e18. PubMed ID: 37921602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.